NasdaqCM - Delayed Quote USD

Organovo Holdings, Inc. (ONVO)

1.0000 0.0000 (0.00%)
At close: April 24 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Keith E. Murphy Executive Chairman 762.74k -- 1972
Mr. Thomas P. Hess CPA, MBA President & CFO 199.32k -- 1964
Ms. Vaidehi Joshi Director of Discovery Biology & Director 91.8k -- 1987
Dr. Curtis M. Tyree Ph.D. Senior Vice President of Strategy & Business Development -- -- --

Organovo Holdings, Inc.

11555 Sorrento Valley Road
Suite 100
San Diego, CA 92121
United States
(858) 224-1000 https://www.organovo.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
18

Description

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.

Corporate Governance

Organovo Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Apr 23, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing
  • Apr 12, 2024
    S-1: Offering Registrations
    See Full Filing
  • Feb 07, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing
  • Feb 06, 2024
    CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
    See Full Filing
  • Jan 26, 2024
    S-3: Offering Registrations
    See Full Filing

Upcoming Events

Jul 11, 2024 - Jul 15, 2024
Organovo Holdings, Inc. Earnings Call

Related Tickers

SNGX Soligenix, Inc.
0.3830
-4.25%
 
LGVN Longeveron Inc.
1.7200
-5.49%
 
ADIL Adial Pharmaceuticals, Inc.
1.7100
+0.59%
 
PXMD PaxMedica, Inc.
0.6920
-3.35%
 
NKGN NKGen Biotech, Inc.
1.7100
-7.57%
 
RLYB Rallybio Corporation
1.5800
-9.20%
 
PALI Palisade Bio, Inc.
6.35
+7.26%
 
CLNN Clene Inc.
0.3370
+0.57%
 
ALLR Allarity Therapeutics, Inc.
1.3700
-3.52%
 
ABVC ABVC BioPharma, Inc.
1.4800
+9.63%